Crowdonomics
PROJECT TRANSCEND

Reg CF · Common Stock · Dec 2022

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$52K / $1.2M max
4% of ceiling · target hit day 3
Investors
35
$1.6K avg
Post-money valuation
$14.6M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$55K$28K$0
35180
Dec 9, 2022 · openedFeb 8, 2023 · last reading
Target ($10K) hit — Dec 12, 2022, day 3Deadline Feb 7, 2023

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
−$79K
FY2020
$0
−$297K
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$78,893
-$297,332
Taxes paid
$0
$0
Balance sheet
Cash
$37,382
$54,825
Accounts receivable
$0
$0
Total assets
$37,382
$54,825
Short-term debt
$2,161
$66,936
Long-term debt
$504,500
$754,500
Total liabilities
$506,661
$821,436
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$14.5M
Post-money$14.6M
Price / share$1.32
Shares offered7,576

Perks

Invest within the first week and receive 15% bonus shares · until Dec 15, 202215% bonus

Offering details

Target$10,000
Max$1,235,000
Min investment$149
OpenedDec 9, 2022
DeadlineFeb 7, 2023
ClosedFeb 7, 2023
Days active60

Links & provenance

Source: Manual
0001665160-22-003041
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.